Venus Concept

Venus Concept OCF Margin

Delisted

The Operating Cash Flow Margin of Venus Concept (VERO) as of Oct 22, 2026 is -17.07 %. In the previous year, Operating Cash Flow Margin was -16.84 % — a change of 1.35% (lower).

OCF Margin

-17.07 %

YoY

1.35%

Last updated:

Operating Cash Flow Margin of Venus Concept is 2024 -17.07 % . Operating Cash Flow Margin of Venus Concept was 2023 -16.84 % . It decreases by 1.35% lower compared to the previous year.

The Venus Concept OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2017
-90.42 USD
Jan 1, 2018
-130.71 USD
Jan 1, 2019
-35.86 USD
Jan 1, 2020
-36.72 USD
Jan 1, 2021
-18.72 USD
Jan 1, 2022
-27.12 USD
Jan 1, 2023
-16.84 USD
Jan 1, 2024
-17.07 USD
The Venus Concept OCF Margin history
YEAROCF MarginYoY
-17.07 %+1.35%
-16.84 %-37.89%
-27.12 %+44.86%
-18.72 %-49.03%
-36.72 %+2.40%
-35.86 %-72.56%
-130.71 %+44.57%
-90.42 %-12.74%
-103.62 %-25.98%
-139.98 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Venus Concept Stock analysis

What does Venus Concept do? Venus Concept, Inc. generates revenue through its portfolio of medical aesthetic and hair restoration technologies, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Heal, Venus Skin, and Venus Bliss. The company sells these products to clinics and medical practices globally, operating in over 60 countries and 29 direct markets. Its hair restoration division features NeoGraft, an automated system for follicular unit extraction (FUE) procedures. Venus Viva combines NanoFractional Radio Frequency (RF) and SmartScan technology for facial, neck, and body treatments, while Venus Fiore targets vaginal health restoration with three specialized applicators. The company’s revenue streams include direct sales of devices and related practice enhancement services. Products like Venus Legacy and Venus Freeze Plus are marketed for non-invasive aesthetic procedures, while NeoGraft serves the hair restoration segment. Venus Fiore focuses on internal vaginal health, labia tightening, and mons pubis reduction, addressing niche medical needs. All offerings are distributed through the company’s global network, leveraging its presence in 29 direct markets. Venus Concept’s business model centers on selling minimally invasive and non-invasive medical aesthetic technologies to healthcare providers. The company’s product range spans multiple applications, from facial rejuvenation to hair restoration and intimate health. By maintaining a diverse portfolio under its branded products, Venus Concept ensures steady demand across various medical specialties and geographic regions. Venus Concept is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Venus Concept stock

Operating Cash Flow Margin of Venus Concept is -17.07 % in 2024.

Operating Cash Flow Margin of Venus Concept changed from -16.84 % to -17.07 %, representing a 1.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Venus Concept since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Venus Concept with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Venus Concept

All Key Metrics — Venus Concept